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Abstract Effects of a set of a-ketoglutarate phosphoanalogues 
on the activity of a-ketoglutarate dehydrogeoase (EC 1.2.4.2) 
complexes from E. coli and pigeon breast muscle, as well as on a- 
ketoglutarate dehydrogeoase isolated from the pigeon breast 
muscle, have been studied, a-Ketoglutarate phosphoanalogues 
(sueeinyl phosphonate and its monomethyl ester) were found to 
be effective inhibitors of a-ketoglutarate oxidative decarboxyla- 
tiont catalyzed by both nmsde and bacterial a-ketuglutarate 
dehydrogenase complexes, as well as muscle a-ketoglutarate 
dehydrogenase. The ability of glutamate phosphoanalogues to 
Inhibit a-ketoglutarate oxidative decarboxylation has been 
shown in F.. coil extract and a model system. 
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logues of Pyr [1-5] and corresponding amino acid precursor 
[6-9]. The feature of inhibition of pyruvate dehydrogenase 
was investigated by phosphoanalogaes of Pyr, modified at 
phosphorus containing fragment [5]. 
In this work we have studied the effect of a set of a-Kglu 
phosphoanalogues (succinyl phosphonate, Sue-P, and appro- 
priate esters) on the activity of a-ketoglutarate d hydrogenase 
complexes (a-KGDC) from E. coli and pigeon breast muscle, 
as well as on a-KGD isolated from the pigeon breast muscle. 
In addition, we have studied the possibility of metabolic trans- 
formation of the glutamate phosphoanalogues, l-amino-3-car- 
boxypropyiphosphonic (Glu-P) and -phosphinic (Glu-P.) 
acids into dehydrogenase inhibitors in a model system and 
extract of E. coli. 
2. Materials and methods 
1. Introduction 
a-Keto acids, especially those produced from natural amino 
acids, are of considerable importance for the cell metabolism. 
Thus pyruvic acid (Pyr) is a connecting link between the ni- 
trogen and carbohydrate pathways of metabolism, whereas 
oxaloacetic (Oxa) and a-ketoglutaric (a-Kglu) are intermedi- 
ates of the tricarboxylic acid cycle. The interconversions of a- 
keto acids and amino acids play an important role in nitrogen 
metabolism. 
The Pyr and a-Kglu oxidative decarboxyh,:,ion supplies the 
bulk of carbon atoms, involved in the Krebs cycle as acetyl- 
and succinyl-CoA, and for this ~'eason the problem of selective 
inhibition of these processes is important. A perspective ap- 
proach to creation of oxidath,e decarboxylation i hibitors can 
be usage of phosphonic analogues of a-keto acids, in which 
carboxylic group is replaced with an acidic phosphorus con- 
taining fragment and in which the phosphorus-carbon bond is 
resistant o action of amino acid metabolism enzymes. These 
substances can be synthesized and used as such in isolated 
systems or arise in vivo from metabolic precursors, such as 
phosphoanalogues of a-amino or hydroxy acids. The validity 
of this approach as been demonstrated by effective inhibition 
of acetyl-CoA formation in vitro and in vivo by phosphoana- 
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2.1. Chemical compounds 
NAD +, thiamine pyrophosphate (TPP), cysteine hydrochloride, a- 
ketoglutarate, and oxaloacetate were purchased from Sigma (USA). 
Phosphoanalogues of pyruvate, a-kctoglutarate, and glutamate (see 
I-~ig. 1) were obtained according to [10] and [!!,12], respectively. 
The other chemicals were of the purest grade available. 
2.2.~,Enzyme preparations and their activity determination 
E~c~act of E. coil was prepared according to the method escribed 
in [8].'~solation f a-KGDC from E. coil and its activity determina- 
tion by ~,NAD ÷ reduction were carried out using a modified technique 
[13]. Th~,a-KGDC and a-KGD isolation from pigeon breast muscle 
and deten~,ination f their activities were done by the earlier described 
methods [i\,[]. The isolation of aspartate aminotransferase (EC 2.6.1.1) 
from pig-hd:~rts and the enzyme activity determination by accumula- 
tion of oxalo,~cetic a id were carried out according to [12]. In all cases 
the initial rate.kof enzymatic reaction was measured. 
In the case o~ phosphoanalogue of a.keto acids and a-KGDC and 
a-KGD the reac~.on was initiated by the enzyme addition. Preincuba- 
tion of a-Kglu p~asphoanalogues with a-KGD (5 rain) was carried 
out in a cell for t~te activity determination i 0.05 M K-phosphate 
buffer, pH 6.3. In tl~is case the enzymatic reaction was initiated by the 
simultaneous additio's~ ofa.Kglu and ferricyanide up to final concen- 
trations of 0.5 mM a~d 0.6 raM, respectively. 
2.3. The effect of Glu.l'xand Glu-Pil on dehydrogenase activity in 
E. coil extract and in a ~:~odel system 
50 I~1 of fresh E. coil extract was added to 50 ~tl of incubation 
mixture that contained 50 mM of K-phosphate buffer, pH 7.4, 2.6 
mM L-cysteine, 1mM MgCI2, and 2.0 mM Pyr. In some cases 0.1 mM 
of aminooxy acetate was added. The mixture also contained 5mM of 
one of gluphosphoanaiogues. Theincubation was carried out at 370C 
for 6 h. An aliquot (10 ~1) was taken at definite intervals of time to 
determine a-KGDC activity using the above method. 
In the model system purified enzyme preparations ofaspartate ami- 
notransferase from pig hearts and a-KGDC from E. coli were used. 
The Glu phosphoanalogues were incubated with aspartate amino- 
transferase under conditions imilar to those described in [12], then 
aliquots were taken and added to the incubation mixt' v." for determi- 
nation of a-KGDC activity. 
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Table I 
Inhibition of a-KGD and a-KGDC from pigeon breast muscle and a-KGDC from E coil by a-Kglu phosphoanalogues a 
Source of enzyme Enzyme Experiment Compound Concentration f Relative activity 
number analogue (mM) (%) 
E. coil a-KGDC I Suc-P 0.02 5 
Suc-P~1 0.02 50 
SuC-PDM 0.02 I00 
Suc-P+2 mM a-Kglu 0.02 33 
a-KGDC 2 Suc-P 0.06 2 
Suc-PM 0.06 25 
SuC-PD~! 0.06 100 
Pigeon breast muscle a.KGDC 3 Suc-P 0.06 38 
Suc-P~1 0.06 67 
SuC-PDM 0.06 98 
a-KGD 4 
a.KGD 5 t' 
Suc-P 0.06 20 
Suc-PM 0.06 40 
Suc-Pr~! 0.06 100 
Suc-P 0.02 4 
Suc-PM 0.02 40 
Suc-PD~t 0.02 92 
Suc-P + 0,5 mM a.KGlu 0.02 25 
~Aetivity of enzymes was determined in the presence of0.5 mM a-Kglu. The Km value for a-Kglu in 
0.07 raM. The K~i~, value for a-Kglu in the case of muscle a-KGD is 0.02 mM [14]. 
bActivity of a-KGD was determined after preincubation for 5 min in the presence ofanalogue. 
the case of E coil a-KGDC is equal to 
3. Results and discussion 
3.1. Succinyl phosphonate inhibits oxydative decarboxylation f
a.ketoglutarate 
At the first step we have studied the influence of Suc-P and 
its esters on a-Kglu oxydative decarboxylation, catalyzed by 
a-KGD and a-KGDC from pigeon breast muscle, as well as 
by a-KGDC from E. coll. The Suc-P interaction with com- 
plexes was competitive in relation to the substrate, i.e. an 
increase of a-Kglu concentration resulted in the inhibition 
extent decrease. Thus, the residual activity of E, coli a- 
KGDC was equal to 33% in the presence of 0.02 mM Suc-P 
and of 2 mM of a-Kglu, whereas it made up only 5% in the 
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Scheme 1 
case of 0.5 mM of a-Kglu (Table 1, experiment 1). This com- 
petition was also shown for a-KGD (Table !, experiment 5): 
in ti,,e presence of a-Kglu 25% of activity was preserved, while 
preincubation with Suc-P in the absence of a-Kglu caused 
practically complete inactivation of a-KGD. 
The inhibition of wKglu oxidative decarboxylation by 
phosphoanalogues was selective, since millimolar concentra- 
tions of Ac-P and AC-PH did not inhibit a-KGDC and a- 
KGD activities. We have found in experiments with isolated 
a-KGD (Table 1, experiments 4 and 5) that the level of en- 
zyme inhibition by Suc-P increases upon preincubation with 
inhibitor. A similar effect was observed uring Pyr phospho- 
analogues interaction with pyruvate dehydrogenase from E. 
coli and this was explained by enzyme-inhibitor complex (E- 
I) isomerization [15]. A similar level of inhibition of a-KGD, 
preincubated with analogue (Table 1, experiment 5), and a- 
KGDC from E. coil without preincubation (Table 1, experi- 
ment 1), could be interpreted as a difference in the stability of 
E-I complexes of muscle a-KGD and bacterial enzyme This 
correlates with the possibility of conformational lterations of 
the muscle a-KGD during catalysis [16]0 which is typical for 
bacterial enzymes. The difference in the properties of E-I com- 
plexes may explain th,: lower sensitivity of muscle a-KGDC 
towards inhibitors (Table 1, experiment 3), as of bacterial one 
(Table 1, experiment 2). It should be noted that the substrate 
affinities for the muscle dehydrogenase and bacterial enzyme 
are close to each other and are equal to 0.02-0.04 mM [14] 
and 0.07 raM, resp~tively. 
The data in Table 1 show that the inhibitory activity of Suc- 
P in all cases was higher than that of monomethyl esterlof the 
same compound. The opposite situation has been observed for 
pyruvate dehydrogenase complex inhibition by pyruvate phos- 
phoanalogues. According to the literature [2] and our own 
data [4,7], the most effective inhibition of pyruvate dehydro- 
I A related fluorescent substance, monomethyl ester of pyrene butyl 
phosphonate, has a sufficient affinity to the enzyme [13]. 
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Fig. I. Inhibition of a-KGDC activity in E. coil extract after incl~t- 
bation with Glu phosphoanalogues. For incubation conditions ee 
section 2. a-KGDC activity was determined at 37°C in 0.99 ml of 
K-phosphate buffer, pH 7.4, containing 2.6 mM L-cysteine, 1 mM 
MgCI2, 0.2 mM TPP, 2.5 mM NAD, 0.1 mM CoA, and 2 mM a- 
Kglu. The reaction was initiated by addition of a 10 pl aliquot of 
incubated E. coil extract containing: (o) 2 mM Pyr; (.) 2 mM 
Pyr+5 mM Glu-P; (12) 2 mM Pyr+5 mM Glu-PH; (×) 2 mM 
Pyr+5 mM Glu-P+0.1 mM aminooxy acetate; (+) 2 mM Pyr+5 
mM Glu-PH + 0.1 mM aminooxy acetate. 
genase complex was caused by acetyl phosphonate mono- 
methyl ester. Dimethyl ester of Suc-P, lacking a negative 
charge on its phosphonate fragment, was inactive. 
So, obtained data show that Suc-P and corresponding 
monoester are effective inhibitors of a.Kglu oxidative decar- 
boxylation, catalyzed by both muscle and bacterial a-KGDs. 
The mechanism of inhibition may include the interaction of 
inhibitor carbonyl group with TPP in the a-KGD active cen- 
ter similarly to the earlier proposed mechanism of pyruvate 
phosphoanalogues interaction with the pyruvate dehydrogen- 
ase complex i rom E, coli [2]. 
3.2. Generation of inhibitors of a.Kglu oxidative 
decarboxylation from glutamate phosphoanalogues 
( Glu-P and Glu-Pn ) in transaminase r action and 
extract of E. coil 
Earlier we have shown the possibility of transamination f 
amino acid phosphoanalogues to corresponding keto acids in 
vitro [12], in vivo [6,8], and in E. coil extracts [7-9]. 
We applied the same approach in present paper to generate 
dehydrogenase reaction inhibitors using glutamate phospho- 
analogues and E. coil extract and aspartate aminotransferase. 
As is seen from Fig. I, incubation of GIu-P or Glu-Plt with 
E. coil extract in 50 mM K-phosphate buffer, pH 7.5 in the 
presence of Pyr results in a drop of a-KGDC activity. Addi- 
tion to the medium of aminoxy acetate, a specific inhibitor of 
enzymatic transamination, retained the dehydrogenase activ- 
ity. 
A possible xplanation consisted in enzymatic transforma- 
tion (transamination) of aminoanalogues into ketoinhibitors 
in E. cell extract, like glutamic acid could be a source of a- 
Kglu in the same system.It has been shown in separate xperi- 
ments that Pyr, GIu-P, and GIu-PH have no inhibitory effect 
on tz-Kglu oxydative decarboxylation. 
In addition, we have studied the transformation f Glu-P 
and GIu-PH into corresponding phosphoanalogues of a-Kglu 
in the system a-KGDC-aspartate aminotransferase. As is 
seen from Fig. 2 in such system a decrease of a-KGDC activ- 
ity observes in the presence of GIu-P or GIu-PH. 
a-KGDC inhibition by Suc-P and the resulting biological 
effect could be observed in vivo if this compound or its meta- 
bolic precursor GIu-P could permeate a cell. However, it is 
known that phosphonates and aminophosphonates poorly 
permeate the cell envelope. Using of GIu-PH may open new 
possibilities, ince the substances of this family are character- 
ized by a good permeability and may transform to the phos- 
phinic inhibitor of a-KGDC, Suc-PH. The latter compound 
has not been synthesized yet and a unique possibility of gen- 
eration of it is metabolic transformation f amino precursor, 
Glu-PH. 
The obtained results confirm the ability of Glu phospho- 
analogues to be metabolic precursors of Suc-P and SuC-PH, 
inhibitors of a-Kglu oxidative decarboxylation. 
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Fig. 2. Effect of a-keto inhibitors, generated during transamination, 
on the E. coli a-KGDC activity, a-KGDC (10 pg/ml) was incubated 
in conditions analogous those indicated in the legend to Fig. 1. The 
reaction was initiated by the simultaneous addition of 5 pl of 2 mM 
a-Kglu and 5 pl of transamination medium containing: (e) 0.3 mM 
Glu+0.002 mM o~-Kglu; (+)0.3 lnM Aspa+0.002 mM a.Kglu; (*) 
0.2 mM Glu.P+0.002 mM a-Kglu; (Q) 0.2 mM Glu-PI;+0.002 
mM a.Kglu. Incubation conditions for transamination as in [12]. 
"As a result of aspartate ransamination Oxa is formed, the effective 
inhibitor of E, coli o~.KGDC (Ki for Oxa = 0,045 mM), 
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